Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

CME Group thrives on market volatility with innovative derivatives, global growth, and strong financials, offering stability, ...

Shares of CME Group Inc. Cl A CME rallied 1.66% to $272.36 Tuesday, on what proved to be an all-around great trading session ...

What Happened: Gerdes's decision to sell 4,000 shares of CME Group was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the sale is $1,060,441 ...

DGRO boasts a low expense ratio, strong liquidity, and a healthy dividend yield. See why I think the fund is a buy.

Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, ...

CME Group Inc. has reported all-time record revenue, adjusted operating income, adjusted net income, and adjusted earnings ...

CME Group's first-quarter earnings fell short due to rising operational expenses, mainly from technology investments, despite ...

CME Group (CME) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.50 per share a year ago. These figures are ...

Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ...

JPMorgan Chase & Co. raised their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Royal Bank o ...

If you're going to take a shot on Lucid Group stock, the key to success will be patience. Anything can happen over the short term. Investors today should be focused on the company's long-term ...